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Heart failure with a normal or nearly normal left ventricular (LV) ejection fraction (HFNEF) may represent more than 50% of
heart failure cases. Although HFNEF is being increasingly recognized, there is a relative lack of information regarding its incidence
and prognostic implications in intensive care unit (ICU) patients. In the ICU, many factors related to patient’s history, or applied
therapies, may induce or aggravate LV diastolic dysfunction. This may impact on patients’ morbidity and mortality. This paper
discussesmethodsforassessingLVdiastolicfunctionandthefeasibilityoftheirimplementationfordiagnosingHFNEFintheICU.
1.Introduction
Diastolic heart failure (DHF) has been described since 1998
[1]. At that time, it was thought to be less frequent than sys-
tolic heart failure (SHF) and have a better prognosis [2].
Nowadays, DHF is known to account for more than 50% of
all heart failure patients, with a similar prognosis to SHF [3–
5]. Diastolic left ventricular (LV) dysfunction is associated
with slow LV relaxation and increased LV stiﬀness [6]. Many
factors can result in DHF such as ventricular hypertrophy,
myocardial ﬁbrosis, inﬁltrative disease, pericardial constric-
tivedisorders,rightventricular(RV)alterationsduetoavari-
ety of causes, advanced age, hypoxia, and acidosis, but most
commonly coronary artery disease (CAD) [3, 4]. Therefore,
DHF may coexist with SHF, leading to the formulation
of a “single syndrome” hypothesis, which postulates that
diastolic LV dysfunction is actually a precursor of SHF and
is due to increased interstitial deposition of collagen and
modiﬁed matricellular proteins [3]. For this reason, experts
propose the term heart failure with normal ejection fraction
(HFNEF) instead of DHF, to indicate that HFNEF could be a
precursor to heart failure with reduced LVEF [3, 4].
Diagnosis of HFNEF requires the presence of heart
failuresymptomsandsigns,withnormalormildlyabnormal
LVEF, (LVEF >50% and LV end-diastolic volume index
<97mL/m2), and evidence of LV diastolic dysfunction [3, 4].
The latter is associated with slow LV relaxation, increased LV
stiﬀness, reduced ventricular compliance, and increased LV
ﬁllingpressure.Thus,itcanbediagnosedinvasivelybymeans
of right heart catheterization (LV end-diastolic pressure
>16mmHg or mean pulmonary capillary wedge pressure
>12mmHg). Alternatively, echocardiography may be used
for noninvasive assessment of diastolic dysfunction. Newer
echocardiographic techniques like tissue Doppler (TD) have
provided indices of LV diastolic dysfunction like the TD
derived E/E  > 15 (early transmitral ﬂow velocity/early TD
diastolic lengthening velocity). If this ratio is inconclusive,
(15 >E / E   > 8), then additional echocardiographic infor-
mation relevant to LV diastolic dysfunction can be derived
by Doppler interrogation of mitral valve or pulmonary veins
or left atrial volume index. Finally, elevated levels of plasma
natriureticpeptidesmayaidinthediagnosisofDHF[3,4,7].
Nagueh et al. provide a simple recommendation for
grading LV diastolic dysfunction by using pulsed Doppler at
the mitral valve and at the mitral annulus [7]. This is brieﬂy
reviewed here but can be seen in full detail in the original
paper [7]. In all forms of diastolic dysfunction left atrial
volume should be greater than 34mL/m2.I nm i l d( G r a d eI )2 Critical Care Research and Practice
diastolic dysfunction, the mitral E/A ratio is <0.8, and the
decelerationtimeoftheEwave(DT)is>200ms.Inmoderate
(Grade II) diastolic dysfunction, the mitral E/A ratio is 0.8–
1.5 and DT is 160–200ms. In severe (Grade III) diastolic
dysfunction, the mitral E/A ratio is ≥2a n dD T <160ms.
The severity of diastolic dysfunction predicts mortality in
longitudinal followup of outpatients [8].
While useful, there are several problems with this clas-
siﬁcation. A reduced mitral E/A ratio may be seen in hyp-
ovolemia. The majority of people >60 years old have E/A
ratios <1a n dD T>200ms and in the absence of other
indications of cardiac disease should be considered normal
[7]. Trained athletes may have enlarged left atrial volumes.
Doppler measurements can show individual variability and
can vary with changes in preload, afterload, and sympathetic
tone. As long as the operator is aware of these factors, the
grading system can be very helpful for clinical practice as it is
a simple method of communicating important information.
Additionally, it can be valuable for research trials as it can
be used to compare diﬀerent populations in a standardized
fashion.
2. LV DiastolicDysfunctioninthe
IntensiveCareUnit(ICU)
In the ICU, there are many scenarios where factors inﬂuenc-
ingLVrelaxation,diastolicdistensibility,andﬁllingpressures
coexist. These factors may be linked to underlying disorders
(CAD, arrhythmia, valvular dysfunction, pericardial disease,
sepsis, and hypoxia), to patients’ history (age, hypertension,
diabetes mellitus, and chronic renal failure), or to applied
therapies (volume resuscitation and positive end-expiratory
pressure (PEEP)). Despite the fact that HFNEF has been
increasinglyidentiﬁed,itsincidenceandimpactonprognosis
in critically ill patients in the ICU remain uncertain. The
ICU-speciﬁc literature is reviewed below, but due to its
sparse nature, extrapolations sometimes have to be made
from the non-ICU cardiology literature. This is not only
due to lack of extensive research in this setting, but also due
to practical diﬀerences in patient populations. The clinical
signs and symptoms of HF required for the diagnosis of
HFNEF may be diﬃcult to recognize in the ICU patient
[3]. The presence of normal or mildly abnormal systolic
LV function, which constitutes the second criterion for the
diagnosis of HFNEF, is easily identiﬁed by echocardiography
with the generally accepted deﬁnition of normal or mildly
abnormal LVEF being >50% [3, 4]. Additionally, normal or
mildly abnormal LVEF depends on the time elapsed between
the clinical heart failure episode and the echocardiographic
examination. Thus, it is recommended that information on
LV systolic function be obtained within 72h following the
heart failure episode. In ICU patients, echocardiographic
examination shouldbe done promptly, oncesigns ofpossible
heart failure are present.
The typical patient seen in the MICU or surgical ICU
diﬀersfromaCCUpatient.IntheCCU,diastolicdysfunction
is often seen in the context of coronary artery disease,
valvular disease, or arrhythmias. While these may be present
in the MICU or SICU patient, there will be a higher per-
centage of sepsis, renal failure, and hypoxemia. In the MICU
or SICU patient there will be a higher incidence of non-
cardiac comorbidity; so diﬀerentiating cardiac from non-
cardiac causes of dyspnea is of great importance. Finally,
there will be a higher percentage of applied therapies that
may aﬀect diastolic heart function such as ﬂuid resuscitation
and positive pressure ventilation.
Importantly the methods used to assess LV relaxation,
diastolic distensibility, stiﬀness, and ﬁlling pressure suﬀer
from many drawbacks in the ICU setting. Hence, even in-
vasive measurements may produce inconclusive results, and
ﬁnding a clinically hypovolemic patient with “normal” pul-
monary artery catheter wedge pressure (PCWP) or a normo-
volemic patient with an elevated PCWP is not uncommon.
Doppler indices of diastolic dysfunction only moderately
correlate with invasive parameters [9, 10]. Also, echocardio-
graphy, which has been widely applied for providing diag-
nostic and monitoring solutions in patients with HFNEF,
carries well-known ﬂaws [3, 4, 7], and some of the newer
echocardiographic techniques (i.e., strain, strain rate, etc.)
may be diﬃcult to conduct in the ICU.
While critical care ultrasound is a growing ﬁeld, the
nature of ICU practice leads to several limitations to ul-
trasound use. Many ICU patients are receiving mechanical
ventilation which may impede imaging of the heart. ICU
patients sometimes cannot be positioned adequately for
all cardiac views. Surgical wounds, dressings, subcutaneous
emphysema, tubes, and foreign devices may obstruct views
[11]. The (at least partial) failure rate of TTE in the ICU
setting has been reported to be between 30 and 40% in older
studies [12, 13]. Contrast echocardiography or harmonic
imaging can help in some cases [14]. Also, many of these
limitations can be overcome with the use of TEE when
clinically indicated. With proper training, noncardiologist
intensivists can perform adequate TEE examinations [15,
16].
The presence of concentric LV remodeling may have
important implications for the diagnosis of HFNEF, and an
increasedLVwallmassindexmayprovidesuﬃcientevidence
for the diagnosis of HFNEF when TD yields nonconclusive
results or when plasma levels of natriuretic peptides are
elevated [3]. The latter, (Atrial natriuretic peptide (ANP)
and brain natriuretic peptide (BNP)) are produced by atrial
and ventricular myocardial cells in response to an increase of
atrial or ventricular diastolic stretch and mediate natriuresis,
vasodilation, and improved LV relaxation. Their diagnostic
accuracy for HF has been established, and combination with
TD-derived E/E   ratio may prove an extremely valuable tool
in the ICU setting for diagnosis of HFNEF [3, 4]. Finally, left
atrial enlargement and/or evidence of atrial ﬁbrillation are
considered adjunctive evidence for the diagnosis of HFNEF
[3, 4].
Recent studies have linked the presence of diastolic dys-
function to weaning failure in the critically ill [17–19]. Pa-
panikolaou et al. have studied a small series of critical care
patients with preserved LV systolic function and reported
that weaning failure was related not only to grade III but
also to grade I diastolic dysfunction [17], while Caille et al.Critical Care Research and Practice 3
reported similar results in 117 unselected patients; however
diastolic dysfunction was often associated with systolic dys-
function in the latter series [18]. Lamia et al. discovered that
an increase in LV ﬁlling pressures related to spontaneous
breathing trials (SBTs) was predictive of weaning failure in
a highly selected population (patients with two preceding
failed SBTs, and approximately 20% of them had a decreased
LVEF) [19]. In outpatients, relaxation impairment of the LV
can be unmasked by performing Doppler echocardiography
during exercise [20]. In the ICU, weaning trials can be
considered as exercise due to increments in respiratory and
cardiovascular load and in oxygen demand [17–21]. Hence,
weaning may reveal subtle diastolic dysfunction in the ICU.
Another issue associated with LV diastolic dysfunction,
which is largely unstudied, is its possible relation to acute
loading and unloading conditions of the LV commonly
observed in the ICU. An LV with diastolic dysfunction is
considered in cardiodynamic terms volume sensitive hence
exploring those echocardiographic indices as aids to guide
ﬂuid loading or unloading is of great clinical interest. Tissue
Doppler indices might be extremely useful in this regard, as
E  can be conceptualized as the amount of blood entering
the LV during early ﬁlling, whereas E represents the gradient
necessary to make this blood enter the LV. Therefore, a
high E/E
  represents a high gradient for a low shift in vol-
ume [3]. Additionally, echocardiography may be used with
adjunctive lung ultrasound examination, as the latter may
identify alveolar-interstitial syndrome by evaluating lung-
rocket artifacts (B-lines) that may provide additional infor-
mation about lung water [22, 23].
Theconceptofisolateddiastolicdysfunctionisbecoming
a new trend in cardiodynamic analysis; however, as previ-
ously mentioned, cases which have been characterized as iso-
lated diastolic dysfunction may well exhibit “subtle” systolic
dysfunction [3, 4]. This energy interaction between systole
and diastole will surely produce further pathophysiologic
debate and might also lead towards new concepts in the
development of ventricular assist devices [24]. In theory,
alterations in LV stiﬀness that relate to diastolic dysfunction
might be linked as well to changes in the three-dimensional
(3D) systolic twisting and diastolic untwisting of the LV.
However,theeﬀectsofloadandinotropicstateonLVsystolic
twist and diastolic untwist in human subjects remain to
be studied [25]. The interaction of altered 3D ventricular
geometry with the formatting vortices observed in the LV
by modern magnetic resonance imaging techniques and
complex ﬂuid-structure numerical models may hold the key
tothepathophysiologicdevelopmentofdiastolicdysfunction
[26, 27]. Yet again the latter may represent another example
of phenotypic plasticity, the capacity of a genotype to
exhibit a range of phenotypes in response to environmental
variations [28], reﬂecting a physiologic adaptation of the
ventricle to altered myocardial cell structure and disturbed
ﬂow patterns in states of cardiovascular disease [29, 30].
Furthermore, LV tolerance to ﬂuid loading might be
better monitored by ultrasound in common scenarios such
astheresuscitationofsepticshock.Inthelatter,experimental
models and clinical studies have previously reported that
apart from systolic dysfunction, alterations in LV stiﬀness
and various grades of diastolic dysfunction may exist [31–
37]. In such patients, diastolic dysfunction seems to be an
independent predictor of mortality [31].
Consideration should be given to the issue of training of
intensivists in echocardiographic analyses of patients with
diastolic dysfunction. In the United States, only 55% of
critical care fellowship programs provide training in echo-
cardiography [38]. How many of these provide training
in analysis of diastolic dysfunction is unknown as this is
not recommended by recent guidelines [39, 40]. In our ex-
perience, the extra training time required to perform basic
analysis of diastolic dysfunction is not excessive. However,
depending on the skill of the examiner and the clinical
scenario, advanced consultation from expert-level echocar-
diographers may be required.
Despite the fact that we have still much to learn about
many of the above-mentioned mechanisms, by integrating
sophisticated “functional cardiac imaging” techniques with
current research our clinical understanding of the speci-
ﬁcities encountered in critical care patients who may present
with LV diastolic dysfunction will be improved. Knowledge
of diastolic dysfunction should not be considered a sophisti-
cated approach designated only for cardiologists but should
be familiar to all intensivists.
3. Conclusion
Although HFNEF is being increasingly recognized, there
is a relative lack of information regarding its incidence
and prognostic implications in the critically ill. There may
be diﬃculties in the implementation of criteria for the
diagnosis of HFNEF in the ICU. However combination of
simple echocardiographic indices of LV diastolic dysfunction
like TD-derived E/E
  with other simply derived echocar-
diographic parameters like left atrial size, or presence of
left ventricular hypertrophy with natriuretic peptides, may
prove invaluable tools for studying the role of diastolic LV
dysfunction in such patients.
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